Page last updated: 2024-08-23

epirubicin and FMR1-Related Primary Ovarian Insufficiency

epirubicin has been researched along with FMR1-Related Primary Ovarian Insufficiency in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Lambertini, M; Perachino, M; Poggio, F1
Du, X; Guo, F; Han, Y; Hao, S; Ma, R; Ma, X; Xia, T; Yan, Z; Zhang, Y; Zhou, Y1
Ng, CH; Rozita, AM; Taib, NA; Tiong, V; Yip, CH1
Ahlgren, J; Andersen, J; Andersson, M; Bergh, J; Bjerre, K; Blomquist, C; Lidbrink, E; Lindman, H; Mouridsen, H; Rosendahl, M1
Blomqvist, C; Elomaa, I; Risteli, J; Risteli, L; Saarto, T; Vehmanen, L1
de Jong, FH; de Muinck Keizer-Schrama, SM; Hakvoort-Cammel, FG; Laven, JS; Pieters, R; Themmen, AP; van Beek, RD; van den Berg, H; van den Bos, C; van den Heuvel-Eibrink, MM1

Trials

2 trial(s) available for epirubicin and FMR1-Related Primary Ovarian Insufficiency

ArticleYear
The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study.
    European journal of cancer (Oxford, England : 1990), 2009, Volume: 45, Issue:18

    Topics: Adult; Age Distribution; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Leukocyte Count; Leukopenia; Menstrual Cycle; Middle Aged; Primary Ovarian Insufficiency

2009
Short-term intermittent intravenous clodronate in the prevention of bone loss related to chemotherapy-induced ovarian failure.
    Breast cancer research and treatment, 2004, Volume: 87, Issue:2

    Topics: Adult; Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Bone Resorption; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Methotrexate; Middle Aged; Premenopause; Primary Ovarian Insufficiency

2004

Other Studies

4 other study(ies) available for epirubicin and FMR1-Related Primary Ovarian Insufficiency

ArticleYear
Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer.
    Breast cancer research and treatment, 2020, Volume: 183, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Docetaxel; Epirubicin; Female; Humans; Ovary; Paclitaxel; Primary Ovarian Insufficiency; Randomized Controlled Trials as Topic; Treatment Outcome; Triple Negative Breast Neoplasms

2020
Menstrual blood derived mesenchymal stem cells combined with Bushen Tiaochong recipe improved chemotherapy-induced premature ovarian failure in mice by inhibiting GADD45b expression in the cell cycle pathway.
    Reproductive biology and endocrinology : RB&E, 2019, Jul-16, Volume: 17, Issue:1

    Topics: Animals; Antigens, Differentiation; Cell Cycle; Epirubicin; Estrus; Female; Fertility Preservation; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice, Inbred C57BL; Ovary; Primary Ovarian Insufficiency

2019
Incidence of chemotherapy-induced ovarian failure in premenopausal women undergoing chemotherapy for breast cancer.
    World journal of surgery, 2014, Volume: 38, Issue:9

    Topics: Adult; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Asia; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Estradiol; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Incidence; Induction Chemotherapy; Menstruation; Middle Aged; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Retrospective Studies; Tamoxifen; Taxoids; Young Adult

2014
Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:10

    Topics: Adolescent; Adult; Age Factors; Age of Onset; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Child; Dacarbazine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Ovary; Predictive Value of Tests; Prednisone; Pregnancy; Primary Ovarian Insufficiency; Procarbazine; Remission Induction; Vinblastine; Vincristine

2007